President and Vice Chairman; formerly President of R&D, Sanofi, OPKO Health
Search every verified Elias Zerhouni interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Elias Zerhouni, Vice Chairman of OPKO Health, was honored with the Distinguished Service Award at an event on April 30, 2026, recognizing his contributions to science, medicine, and industry-academic partnerships. During the ceremony, speakers praised his advocacy for increased NIH funding and basic science research, describing him as a mentor and networker. Zerhouni remarked that he lives the American dream and credited his career opportunities to being in the United States. In his remarks, Zerhouni discussed the lengthy drug development process, citing the example of Dupixent, which he said was developed between 2010 and its first approval in 2017, with multiple indications advanced over about eight years. He also emphasized the importance of continued investment in basic science for the next generation of leaders in the U.S. scientific community.
Honoring Dr. Elias Zerhouni for his vision and life-long commitment to science and medicine, industry-academic partnerships, interdisciplinary biomedical research & development, global health and innovation for a better world.
Dr. Elias Zerhouni joins us on Making Healthcare Work for You to talk about healthcare in the US - He shares where it’s falling behind, and where it’s thriving (spoiler alert, we’re still the best at biomedical research). Dr. Elias Zerhouni is the former NIH Director under George W. Bush, presidential envoy under Barack Obama, and consultant to the White House medical team of President Reagan. Listen in to hear more about: The shift of power from providers to payers Why rational decisions can create irrational outcomes The need to depoliticize and regionalize healthcare Don’t miss this i…
Elias Zerhouni, president of R&D at Sanofi, on immigration in science and the importance of government science funding.
Ushma Neill with the Journal of Clinical Investigation series, Conversations with Giants in Medicine, met Dr. Elias Zerhouni at the Lasker Awards in September of 2023 and jumped at the opportunity to be able to spend an hour with him. Zerhouni, who is professor emeritus at Johns Hopkins University and vice chairman and president of OPKO Health, is a radiologist by training, who focused much of his research on CT- and MRI-based imaging methods to diagnose cancer and cardiovascular diseases. Notably, he served as the director of the US National Institutes of Health from 2002 to 2008 and later as…
USAIC Panel: Industry Academic Partnerships Panelists: Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health Dr. Marcus Schindler, Executive Vice President, Research & Early Development and Chief Scientific Officer, Novo Nordisk Dr. Mathai Mammen, CEO Designate, FogPharma Dr. Phillip Sharp, Institute Professor, Koch Institute, MIT Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen Moderator: Dr. Susan Hockfield, President Emerita, MIT
The Elias A. Zerhouni, M.D. Professorship in the Russell H. Morgan Department of Radiology and Radiological Science and the installation of the inaugural recipient Hanzhang Lu, Ph.D. Professor of Radiology Director, MRI Service Center Chief, NeuroFunction Section Russell H. Morgan Department of Radiology and Radiological Science Johns Hopkins University School of Medicine
Sign in to search the full transcript archive, filter by topic, and access every quote from Elias Zerhouni.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans